VITILIGO DRUGS MARKET ANALYSIS

Vitiligo Drugs Market, by Drug Class (Calcineurin Inhibitors, Corticosteroids, and Psoralens), by Type (Segmental and Non-segmental), by Route of Administration (Oral and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

Published In : Jun 2021
Code : CMI2447
Pages :195
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Vitiligo Drug Market – Restraints

Availability of advanced technologies for vitiligo treatment is expected to hinder growth of the market. False positive reports are also expected to hamper growth of the market. For instance, in October 2018, STRATA Skin Sciences, a manufacturer of innovative products for treatment of skin conditions, announced the launch of XTRAC S3 308nm Laser at the American Society for Dermatologic Surgery meeting. The XTRAC S3 308nm Laser is used for treating skin disorders such as psoriasis and vitiligo. The XTRAC laser utilizes therapeutic ultra-violet B light to treat affected skin areas without damaging surrounding healthy skin.

Restraints & Challenges: